New Delhi : Concerned over ‘wilful violation’ of its drug pricing control rules, the National Pharmaceutical Pricing Authority (NPPA) has slapped show-cause notices on ten top drugmakers for failing to register their products on its online database and submit the mandatory disclosures, reports PTI.
The Authority, which plans to issue notices to more firms that have not furnished the information so far, warned that it would have to launch prosecution, among other legal actions, under the Essential Commodities Act. The NPPA is authorised to cap the drug prices to ensure that the companies do not overcharge for essential medicines while the companies are also required to make certain disclosures and list their products on the Authority’s online database to ensure compliance and transparency. “We have issued notices to top 10 firms that have not registered their products under IPDMS and will be also be issuing notices to others,” NPPA Chairman Bhupendra Singh told PTI. He, however, did not disclose the names of the companies.
